Exclusives

A 375-patient RCT initiated by BioLab Sciences will evaluate the efficacy of human amniotic membrane(s) on difficult-to-heal partial- or full-thickness VLUs in elderly patients with primary outcome of time and frequency of wound closure up to...

InfuSystem announced a US distribution agreement with Smith+Nephew for its NPWT system, Renasys Edge, in home-based care. SmartTRAK notes that Renasys Edge was launched in the US in April 2024. InfuSystem will be a secondary distributor, and...

This meta-analysis showed that late dressing changes significantly increase the risks of wound infection, and changes at 48 hours minimize these risks. There was no advantage demonstrated for earlier dressing changes. Ann R Coll Surg Engl

Integra/ACell received 510(k) clearance for MicroMatrix, a porcine-derived UBM particulate, for an extended shelf-life from 2 to 3 years. It also received 510(k) clearance for Cytal Wound and Burn Matrix, a porcine-derived ECM, for an...

MediWound announced the results of the 239-patient NEXT Protocol. The open-label, single-arm treatment study took place across 29 burn centers. Results showed over 95% of patients achieved complete debridement, with the time to complete...

Management noted its full-thickness RECELL applications are primarily in acute wounds, degloving, necrotizing fasciitis, and severe trauma, with less focus on chronic wounds such as DFUs and VLUs. AVH Q224 Earnings Transcript

Avita enters into an exclusive 5-year development and distribution agreement with Regenity Biosciences for a unique collagen-based dermal matrix. Upon 510(k) clearance expected Q424, Avita will make an initial $2.0MM payment followed by...

MiMedx announces the launch of its first xenograft product, HELIOGEN, a particulate fibrillar bovine collagen matrix for addressing complex wounds primarily in the surgical setting.